You are here

Aplastik Anemili Gebenin Yönetimi: Olgu Sunumu

The Management of a Pregnant with Aplastic Anemia: A Case Report

Journal Name:

Publication Year:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Pregnancy is rarely observed in patients with aplastic anemia. Anemia, hemorrhage and infection may complicate pregnant with aplastic anemia and generally leads to growth restriction, premature labor and intrauterine fetal death. Twenty eight-year-old patient; gravidity 3, parity 2 and 1 alive, was pregnant for 29 weeks and had a history of aplastic anemia. Biochemical analysis and obstetric ultrasonographic examinations were performed during the regular visits. Our patient experienced preterm delivery. Due to late arrival for tocolysis, normal vaginal delivery was performed. Supportive therapy may diminish the rate of maternal and fetal complicatons. It is essential to inform patient and relatives about regular visits and earlier admit¬tance at the time of emergency for minimizing life-threating risks.
Abstract (Original Language): 
Aplastik anemi ve gebelik birlikteliği ender görülür. Annede anemi, kanama ve enfeksiyon görülebilirken, fetüste gelişme kısıtlılığı, erken doğum, intrauterin ölüm izlenebilir. Yirmisekiz yaşında, gravidite 3, parite 2 ve yaşayanı 1 olan hastanın, aplastik anemi tanısı ile 29 haftalık gebeliği mevcuttu. Hastaya belirli aralıklarla obstetrik ultrason ve hemogram bakıldı. Doğum sancılarının olması üzerine başvuran hasta, tokoliz için geç kalındığın¬dan erken doğum yaptı. Destek tedavisi maternal ve fetal komplikasyon oranını düşürebilir. Hastalar olası komplikasyonlar hakkında bilgilendirilmeli, kontrolleri düzenli yapmaları önemle belirtilmelidir. Acil bir durumda erken başvuru yapılması ile hayati komplikasyonlar azaltılabilecektir.
21-22

REFERENCES

References: 

1. Cunningham FG, Leveno KJ, Bloom SL, et al. Heamatological Disorders. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth
JC, Rouse DJ, Spong CY (Editors). Williams Obstetrics. 23rd
edition, USA: McGraw-Hill Companies, 2010: 1085.
2.
Türköz-Suca
k G: Hematolojik Hastalıklar. In: İliçin G, Ünal S, Biberoğlu K, Akalın S, Süleymanlar G (Editors). Temel İç Hastalıkları. 1. Baskı, Ankara: Güneş Kitabevi, 1996: 1194.
3. Arnett C, Greenspoon JS: Hematologic Disorders. In: DeC-herney AH, Nathan L, Goodwin TM, Laufer N (Editors). Cur¬rent Diagnosis and Treatment, Obstetrics and Gynecology. 10th
edition, USA: McGraw-Hill Companies, 2007: 408.
4. Young NS: Aplastic anemia. In: Fauci AS, Braunwald E, Kasper DL et al (Editors). Harrison's principles of internal medicine. 17th edition, New York: McGraw-Hill Companies,
2008: 663.
5. Pavithran K, Thomas M. Pregnancy associated aplastic ane¬mia. J Assoc Physicians India 1996; 4: 273-7.
6. Kwon JY, Lee Y, Shin JC, Lee JW, Rha JG, Kim SP. Suppor¬tive management of pregnancy-associated aplastic anemia. Int J Gynaecol Obstet 2006; 95: 115-20.
7. Deka D, Banerjee N, Roy K, Choudhry VP, Kashyap R.
Aplastic anemia during pregnancy: Variable clinical course and outcome. Eur J Obstet Gynecol Reprod Biology 2001; 94:
152-4.
8. Deka D, Malhotra N, Sinha A, Banerjee N, Kashyap N. Preg¬nancy associated aplastic anemia: Maternal and fetal outcome. J Obstet Gynaecol Res 2003; 29: 67-72.
9. Feig SA, Champlin R, Arenson E et al. Improved survival following bone narrow transplantation for aplastic anemia. Br
J Haematol 1983; 54: 509-17.

Thank you for copying data from http://www.arastirmax.com